You are here: Home » Current Affairs » News » Health
Business Standard

New class of cancer drugs shows more promise

Studies have shown the checkpoint inhibitors can help some patients with kidney, bladder, stomach and other cancers

Andrew Pollack 

Anew drug that unleashes the body's immune system to attack tumors can prolong the lives of people with the most common form of lung cancer, doctors reported on Friday, the latest example of the significant results being achieved by this new class of drugs. In a separate study, researchers said they had found that a particular genetic signature in the tumor can help predict which patients could benefit from the immune-boosting drugs. The finding could potentially extend use of these drugs to some patients with colorectal cancer, prostate cancer and other tumors that have seemed almost ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Sat, May 30 2015. 21:24 IST